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Summary.-The i.v. administration of Corynebacterium parvum (CP) to patients
who had recently undergone resection of colorectal tumours was found to have the
following effects:
1. Polymorphonuclear leucocyte counts were raised 24 h after CP administration,
while both lymphocyte and monocyte counts fell during this period. Polymorph
and lymphocyte counts had returned to pre-infusion levels at one week, but
monocyte counts were significantly increased at this time.
2. The lymphocyte mitotic response to PHA was reduced during the 24 h after CP
infusion.
3. The spontaneous, antibody-induced, and PHA-induced lymphocyte-mediated
cytotoxicity against a nucleated target cell fell significantly 3 h after CP infusion,
but these functions recovered by 7 days.
4. Arise in serum lysozyme was found 3 and 24 h after CP administration. However,
these increased levels were not maintained beyond 24 h.
THE SUCCESS ofCorynebacterium parvunt
(CP) in suppressing the growth of animal
tumours (Scott, 1974) hasled totheevalua-
tion of its role as an immunotherapeutic
agent in human malignancy. The investi-
gationofthe effects ofthis agent on human
immune reactions is of obvious import-
ance for understanding its effects on
patients, and to assist rational schedul-
ing of immunotherapy. There are few
reports of systematic studies of such
effects of CP in healthy patients not
receiving any other treatment in the form
of chemotherapy or radiotherapy.
The study reported here involved
patients whose only previous treatment
had been tumour resection, and who were
ingoodhealth andclinically freeoftumour.
In view of the suppression of lymphocyte
function by CP which has been reported
in animal systems (Scott, 1972a; Allwood
& Asherson, 1973) monitoring of lympho-
cyte function during and after treatment
was considered clinically desirable as well
as scientifically important.
PATIENTS AND) METHOI)S
The patients consisted of 11 recently
diagnosedcasesofcarcinoma oftherectumwho
had undergone potentially curative resection
oftheir tumours within the 30 days preceding
immunotherapy. They had all made a satis-
factory recovery and were readmitted for
their first infusion of CP, on which the work
described in the present study is based.
Immnu)otherapy. Corynebacterium parvurm
(Welleome Laboratories, Beckenham, Kent)
5 mg/M2 was administered i.v. over 1 h in
normal saline, and vital signs were monitored
hourly for 24 h. The i.v. route wNas chosen on
the basis of experimental observation that
this produced a greater anti-tumour effect
than s.c. administration (Castro, 1977). The
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dose used had been previously reported to be
associated with mild clinical consequences in
Phase I studies (Reed et al., 1975).
Blood counts. Differential white cell and
platelet counts were made in the Haematology
Laboratory of the Nuffield Department of
Medicine. For monocyte counts, smears were
stained as described by Yam et al. (1971).
Cytotoxicity assays. A whole-blood method
was used (Gale & MacLennan, 1976). Heparin-
ized blood was diluted 1: 5 and 1:10 in mini-
mal essential medium plus 10% foetal calf
serum (MEM/FCS) with 20 units preservative-
free heparin per ml. 500juO aliquots were
added to 3 sets oftriplicate 72 x 12mm plastic
tubes. To one set, 2 x 104 5ICr-labelled Chang
cells, in 500 1l of the above medium, were
added: to the second set, 2 x 104 Chang cells
plus 1:10,000 rabbit anti-Chang antibody;
and to the third set, 2 x 104 Chang cells plus
1:150 reagent-grade phytohaemagglutinin
(PHA) (Welleome). The tubes were tightly
capped and incubated at 37°C for 20 h. The
tubes were then centrifuged at 200 g for 5 min,
and 500 1A of supernatant removed. Pairs of
pellet and supernatant tubes were counted
in a gamma counter and the 0% 51Cr release
calculated.
Specific Cytotoxicity was derived asfollows:
(observed 51Cr release
-baseline 51Cr release)
(maximum 51Cr release
- baseline 51Cr release)
Specific cytotoxicity (p) can be converted to
a value z, which is linearly related to the log
ofthe number ofeffector cells:
z=(0P )1oglo
Th-e z values for effector-cell populations in
the blood of a large number ofhealthy donors
approximate more nearly to a normal dis-
tribution than do the corresponding p values,
and hence all cytotoxicity measurements
were transformed to z values for the purposes
of statistical evaluation. Results could then
be expressed as mean z, or converted back to
specific cytotoxicity values for presentation.
No correction was made for the potential
contribution of spontaneous cytotoxicity to
that found in cultures containing antibody
or PHA. The cells responsible for spontaneous
cytotoxicity ("natural killer cells") have not
been shown to be identical to those mediating
antibody- or PHA-induced cytotoxicity, and
the kinetics of the three types of cytotoxicity
are different, making a consistent allowance
for the contribution of spontaneous cyto-
toxicity difficult to apply. In any case. simple
subtraction of p or z values is not accurate,
as many times more effector cells are required
to produce a given level of cytotoxicity in
the absence of a sensitizing agent than in its
presence (MacLennan et al., 1976; Waller &
MacLennan, 1977; Waller et al., 1976).
Mitotic response to PHA.-A whole-blood
method was used (Maini et al., 1973). Heparin-
ized blood was diluted wkith MEM+100% FCS
+20 units preservative-free heparin per ml.
Diluted blood (500 1d) was added to 3 sets of
triplicate 72 x 12mm tubes. PHA (Welleome,
reagent grade) was added in 500 jul ofmedium
to final concentrations of 0, 1:1000 and
3:1000. The tubes were tightly stoppered and
incubated for 68 h, when 1 ,uCi of 3H-
thymidine (Radiochemical Centre, Amer-
sham) was added. Cultures were harvested
at 72 h and the ct/min in the trichloroacetic
acid-precipitated residues measured with a
Beckman counter. Results are expressed as
logio (ct/min in stimulated cultures ct/min
in unstimulated cultures).
Serum lysozyrne. This was estimated on
serum samples using the lyso-plate method
of Osserman & Lawlar (1966).
Statistical methods-.The significance of
changes in lymphocyte number and function
before and after immunotherapy was esti-
mated using the t test for paired data.
RESULTS
The nmean values for all assays at the
various times are showiv in the Table.
Leucocyte counts
The changes following a single infusion
are depicted in Fig. 1. The increase in
polymorphonuclear leucocytes at 24 h is
significant (P<O0001) and large numbers
(19-360o) of the myeloid series in the
blood at this time are juvenile forms.
All patients showed a decrease in
lymphocyte count during the first 24 h
(0 005 >P> 0.001). The reduction in the
numbers ofesterase-positive cells was more
dramatic (P < 0 001) and this initial re-
duction was followed by an increase at
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TABLE
Hours after infusion
Lymphocyte count
Log cells/I
+s.e.
I1
Esterase+ cells
LogNo./I
S.C.
n
PMN leucocytes
LogNo./I1
0
9 19
006
10
8 54
0 09
10
9.53
A A w s.e. O.
n 11
PHA Mitotic response (1:1000)
Log ct/min 3m(
s.e. 0
n 9
3
8 29
0-12
9
7-12
0*08
10
9C30
0 09
11
2 78
0 32
8
95
65
15
8-8
0.2
10
8 07
0 23
10
9.97
0 06
11
1 76
0 50
9
Spontaneous cytotoxicity of 50 tul blood
Mean -0 82(13)* -1 46(3)
s.e. 0.10 0.19
n 9 8
Spontaneous cytotoxicity of 100 H1 blood
Mean -0 62 (19) - 135 (4) - 116 (6)
s.e. 0 12 0 05 0-18
n 9 8 9
Antibody-inCluced cytotoxicity of 50 lI blood
Mean -0-62 (19) -1-46 (3)
S.C. 0 09 0 14
n 10 8
Antibody-induced cytotoxicity of 100 tl blood
Mean -0.45 (26) -1.17 (6)
s.e. 0.10 0-18
n 10 8
PHA-induced cytotoxicity of 50 ,il blood
Mean -0.64 (19) -1.57 (3)
s.e. 0 09 0 18
n 10 8
PHA-induced cytotoxicity of 100 pi blood
Mean -0 46 (26) - 137 (4)
s.e. 0-1 0-19
n 10 8
Serum lysozyme
(Mg/ml)
s.e.
n
6 07
0 58
13
7.77
0 6
13
- 0 90 (10)
0-11
9
-0 63 (19)
0-11
9
- 108 (8)
0-15
9
-0 92 (11)
0-15
9
7 58
0 97
13
Days after infusion
t 7 14
,o 933 928
!o 007 007
9 10
9 08
0 09
10
9 58
0 04
11
3.47
0 22
8
8 72
0 05
10
9.54
0 04
11
3 67
0 30
10
28
9-26
0-06
8
N.T.
N.T.
3 98
0-12
7
- 119 (6) -098 (9) -098 (9) -1 05 (8)
0 17 0 16 0-14 0 17
9 9 10 7
-074 (15)
0 09
9
-058 (21)
0 09
9
-013 (43)
0 09
9
-037 (30)
0o09
9
0 22 (38)
0-12
9
6 39
0-61
13
-0 7 (17)
0-12
10
- 0-58 (21)
006
10
- 026 (35)
008
10
-0.70 (17)
0-15
10
- 0-47 (25)
0-16
10
N.T.
-0.73 (16)
0-14
7
-0 74 (15)
0-12
7
- 0 35 (31)
0-12
7
-0 61 (20)
0-12
7
-0 29 (34)
0-13
7
N.T.
* Cytoxicity expressed as % specific cytotoxicity in parentheses.
7 days (P < 0.01). Twenty-four hours after
infusion some patients showed recovery
of the numbers of esterase-positive cells,
but these monocytes were smaller and
contained reduced numbers of esterase-
positive granules compared with the cells
present before infusion.
Mitogenic response to PHA
There was a reduction in the mitotic
response to PHA at 3 and 24 h after CP
administration (Fig. 2). In the case of the
suboptimal stimulating dose of PHA,
significant suppression was observed at
both times (0.005 >P> 000IandP < 000I
respectively). At the optimal dose ofPHA,
significant suppression was present only
at 24 h (P < 0001).
Lymphocyte cytotoxicity against Chang cells
The changes in cytotoxic activity fol-
lowing CP administration are shown in
Figs 3, 4 and 5.
The cytotoxicity of 100 u1d of blood fell
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FIG. 1. Counts of lymphocytes, esterase-
positive cells and polymorphonuclear leuco-
cytes in patients undergoing C. parvum
immunotherapy. (Mean log number of
cells/litre + s.e.).
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FIG. 2. The mitotic response of 100 I- whole
blood to two doses of PHA in patients
undergoing C. parvum immunotherapy.
in all 3 assays, 3 hafterinfusion (P < 0 001 ).
There was some recovery at 24 h, and
subsequently a slight increase above the
initial values was seen at 7 days. This
increase was significant only for antibody-
and PHA-induced cytotoxicity (P < 0.025).
28 days after the infusion, the levels of
cytotoxicity were not significantly differ-
ent from the initial values.
Serum lysozyme
This enzyme was measured because it is
present in cells of the macrophage series
and because it has been suggested that it
may be one index of macrophage-medi-
ated resistance to tumour in humans
(Currie, 1976). Increased levels were
recorded at 3 and 24 h after CP was given,
and these increases were statistically sig-
nificant (P < 0a002 and P < 0a02 respec-
tively). The levels were, however, begin-
ning to fall in some patients by 24 h, and
these increases were not subsequently
maintained (Fig. 5).
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FIG. 3.-The spontaneous cytotoxicity of
50 ,ul (-* ) and 100 l (- O --) of
whole blood against Chang cells. Results
areexpressed asmeanz + s.e.,reconvertedto
specific cytotoxicity values for presenta-
tion.
DISCUSSION
The effect of i.v. infusion of Corynebac-
terium parvum on peripheral-blood leuco-
cytes is dramatic, though individual
variation clearly occurs. The changes in
numbers reported in this study confirm
3:1000
1:1000
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FIG. 4. The antibody-induced cytotoxicity
of 50 dul (-* ) and lO0 Il (-O -) of
whole blood against Chang cells. Results
are expressed as mean z + s.e., reconverted
to % specific cytotoxicity.
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FIG. 5. The PHA-induced cytotoxicity of
50 ,tl (-0-) and 100 ,ul ( ) of
whole blood against Chang cells. Results
are expressed as mean z + s.e., reconverted
to % specific cytotoxicitv.
our earlier observation on patients in this
trial (Gill et al., 1977a) and those reported
by other workers (Minton et al., 1976). The
pattern of fluctuation of polymorpho-
nuclear leucocytes and lymphocytes is
reminiscent ofthat seen after i.v. injection
of prednisolone (Clarke et at., 1977); con-
sisting of simultaneous polymorpho-
nuclear leucocytosis and lymphopenia.
This dual effect of CP is delayed by 20 h,
and is possibly mediated through the
endogenous release of corticosteroids from
the adrenals.
The reduced mitogenic response to PHA
reflects the loss of lymphocytes and
possibly monocytes from the peripheral
blood, since the latter have been shown to
J 5
Cl)
4 t/
0 3 24 7
Hours Days
TIME AFTER C. PARVUM
FIG. 6. Serum lysozyme levels (,ug/ml) in
patients undergoing C. parvum immuno-
therapy.
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FIG. 7.-Summary diagram showing the log
deviation from initial level of the lympho-
cyte count, esterase-positive cells, poly-
morphonuclear leucocyte count, and PHA
mitotic response.
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Lymphocyte count
-1_
O Spontaneous cytotoxicity
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FIG. 8. Summary cliagram sho-wing the log
deviation from initial level of tise lymplio-
cyte count an(i tlie, cytotoxicity assays.
be involved in this response (Oppenheim
et al., 1968; Potter & Moore, 1977). How-
ever, the fall in antibody- and PHA-
induced lymphocytotoxicity 3 h after CP
infusion is considerably greater than could
be expected from the drop in lvmphocyte
counts alone.
The i.v. administration of prednisolone
produces a nonsynchronous pattern of loss
of lymphocytes and their cytotoxicity
similar to that found here. However, the
maximal depression of antibody-induced
cytotoxicity by steroids occurs 20 h after
the lowest lymphocyte count. Although a
further loss of cytotoxicity may have
occurred 48 h after CP administration, the
first significant fall, which was measured
at 4 h, cannot be ascribed to the effect of
endogenous steroids. A more likely ex-
planation is that K cells are temporarily
blocked by circulating products resulting
from the infusion, such as antigen-anti-
body complexes formed between the
bacteria and the natural antibodies which
are present in these patients. All the
patients studied were receiving their first
infusion, and a low level of such anti-
bodies might be expected. However, K
cells have been shown to be very sensitive
to the blocking action of such complexes
(MacLennan, 1972). Fibrinogen degrada-
tion products can also interfere with the
expression of lymphocyte responses in
vitro (Ginmann et al., 1976) and these
products are markedly elevated 3 h after
infusion of CP (Cederholm-Williams et al.,
1978) when the mitogenic and cytotoxicity
responses were reduced. Further experi-
ments using isolated lymphocytes are
clearly required to determine whether
alterations in lymphocyte subpopulations
or serum factors are responsible for these
changes.
Thatcher & Crowther (1978) have
demonstrated an initial fall followed by a
rise in cytotoxicity after CP, but differ-
ences in the time at which samples were
assayed and in the methods of quanti-
tating cytotoxicity make direct com-
parisons with their results difficult. Similar
considerations apply to related studies in
cancer patients (Webster et al., 1978) in
whom the mitogenic response to PHIA was
found to be unchanged.
The clinical relevance ofthe suppression
of lymphocyte cytotoxic and mitogenic
activities during the 24 h after CP treat-
ment is uncertain, but it is of interest in
this regard that there was a significant
incidence of herpetic and varicelliform
eruptions in these patients within 24-36 h
ofinfusion (Gill et al., 1 977b). One potenti-
ally important practical point which stems
from these findings concerns the schedul-
ing of CP in clinical protocols. It would
seem desirable to design the frequency of
CP therapy in order to allow immuno-
logical recovery between treatments,
though further studies of such protocols
would be required to confirm this sugges-
tion.
The effect of the monocyte series needs
comment, since it has been suggested in
several animal tumour svstems that CP
produces its anti-tumour effects by in-
creasing both macrophage numbers (Baum
& Fisher, 1972; Wolmark & Fisher, 1974)
and phagocytic function (Scott, 1972b).
The rapid reduction in monocyte nuimber
immediately after infusion is similar to the
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findings of other workers (Minton et al.,
1976) but we also observed a significant
increase 7 days later.
There were also qualitative differences
between the cells of the monocyte series
observed at these times, those present 24 h
after treatment being smaller and with
fewer esterase-positive granules than those
present at 7 days. This, together with the
subsequent increase in numbers, is in
accord with a stimulatory effect of CP on
marrow which has been documented in
mice (Chare & Baum, 1978; Foster, 1978)
and rats (Wolmark & Fisher, 1974). The
timing of these changes closely parallel
those observed in mice, in which increased
plasma levels of marrow colony-stimu-
lating factor were detected within hours
of CP injection (Foster, 1978; Eliopoulos
et al., 1978). Considered in conjunction
with the acute suppression and recovery in
lymphocyte function, the increased mono-
cyte numbers after 7 days suggest that one
rational schedule for CP therapy might be
infusions at 1-2-weekly intervals, rather
than the monthly schedule which is
currently widely used clinically. This
suggestion would require confirmation by
further studies, but Hedley et al. (1979)
have recently published data on monocyte
function which also suggest that adminis-
tration more often than every 4 weeks may
be more appropriate in humans. These
workersalsodemonstratedincreased mono-
cyte function using small intradermal
doses ofCP.
The increase in serum lysozyme levels
was significant, but transient. This
enzyme is present in both polymorphs and
macrophages, but recent clinical and
experimental studies have proposed that
its measurement provides one parameter
of macrophage-mediated defence against
tumours (Currie, 1976). Its infusion does
not follow the change in numbers ofmono-
cytes, and the changes observed probably
represent the rapid release from mature
cells of the granulocyte and macrophage
series. The increase in lysozyme does,
however, closely parallel the enormous
increase in fibrinolytic activity which we
have observed in these patients (Ceder-
holm-Williams et al., 1978) and it is in-
teresting to note that both lysozyme and
plasminogen activators are important
secretory products of macrophages (Gor-
don, 1976).
Although we have demonstrated con-
sistent transient suppression of lympho-
cyte function in the blood ofthese patients
immediately after infusion, this should not
necessarily be regarded as a contra-
indication to such immunotherapy. We
take this view because of the rapid re-
covery which occurs; because no sus-
tained immunosuppression was demon-
strable in patients who had had multiple
infusions (Waller et al., 1980); and because
in animal tumour systems CP still exerts
its anti-tumour effect, despite concomitant
immunosuppression.
We are grateful to Mlr Brian Walker for skilled
technical assistance and to Mliss E. J. Howes for
carrying out the white-cell counts an(d differentials.
We are also indebte(d to Dr S. Gorcdon for helpful
dliscussion.
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